ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

IMCC IM Cannabis Corporation

2.45
-0.32 (-11.55%)
After Hours
Last Updated: 23:18:52
Delayed by 15 minutes
Share Name Share Symbol Market Type
IM Cannabis Corporation NASDAQ:IMCC NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.32 -11.55% 2.45 2.46 2.56 2.81 2.40 2.74 34,245 23:18:52

IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET

06/11/2024 1:00pm

PR Newswire (US)


IM Cannabis (NASDAQ:IMCC)
Historical Stock Chart


From Oct 2024 to Dec 2024

Click Here for more IM Cannabis Charts.

TORONTO and GLIL YAM, Israel, Nov. 6, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third 2024 ended September 30, 2024, on November 14, 2024, before the market opens.

IM_Cannabis_Logo

The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration.

If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com/ within 24 hours after the call.

Link for the to register for the zoom call: https://us02web.zoom.us/webinar/register/WN_1McuNcK_R62gmx7a3BplLg#/registration

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has focused its resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Logo - https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Company Contact:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/im-cannabis-to-report-third-quarter-2024-financial-results-on-thursday-november-14th-at-900am-et-302297449.html

Copyright 2024 PR Newswire

1 Year IM Cannabis Chart

1 Year IM Cannabis Chart

1 Month IM Cannabis Chart

1 Month IM Cannabis Chart

Your Recent History

Delayed Upgrade Clock